AR027122A1 - Composicion paa el tratamiento de tejidos danados - Google Patents
Composicion paa el tratamiento de tejidos danadosInfo
- Publication number
- AR027122A1 AR027122A1 ARP000106960A ARP000106960A AR027122A1 AR 027122 A1 AR027122 A1 AR 027122A1 AR P000106960 A ARP000106960 A AR P000106960A AR P000106960 A ARP000106960 A AR P000106960A AR 027122 A1 AR027122 A1 AR 027122A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- composition
- donated
- fabrics
- wound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Se describe un agente farmacéutico para uso en el tratamiento (por ejemplo, curacion) de tejidos danados, tal como una herida, comprendiendo el agentefarmacéutico una composicion que comprende: (a) un factor de crecimiento; (b) un agente inhibidor; y , opcionalmente (c) un vehículo, diluyente o excipientefarmacéuticamente aceptable; pudiendo el agente inhibidor inhibir la accion de al menos una porteína adversa específica (por ejemplo, una proteasa específica)que está regulada positivamente en un entorno de tejido danado, tal como una herida.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9930768.8A GB9930768D0 (en) | 1999-12-29 | 1999-12-29 | Composition |
Publications (1)
Publication Number | Publication Date |
---|---|
AR027122A1 true AR027122A1 (es) | 2003-03-12 |
Family
ID=10867127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000106960A AR027122A1 (es) | 1999-12-29 | 2000-12-27 | Composicion paa el tratamiento de tejidos danados |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1242120A2 (es) |
JP (1) | JP2003519193A (es) |
AR (1) | AR027122A1 (es) |
AU (1) | AU1878201A (es) |
CA (1) | CA2395487A1 (es) |
CO (1) | CO5271671A1 (es) |
EC (1) | ECSP003859A (es) |
GB (1) | GB9930768D0 (es) |
GT (1) | GT200000224A (es) |
PE (1) | PE20011095A1 (es) |
UY (1) | UY26514A1 (es) |
WO (1) | WO2001049309A2 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7034132B2 (en) | 2001-06-04 | 2006-04-25 | Anderson David W | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
ES2304401T3 (es) | 2000-10-16 | 2008-10-16 | Genentech, Inc. | Metodos de tratamiento que utilizan polipeptidos wisp. |
DK1414487T3 (da) | 2001-07-27 | 2006-10-09 | Orthologic Corp | Anvendelse af thrombin-peptidderivater til behandling af kroniske hudsår |
WO2003029819A1 (fr) * | 2001-09-28 | 2003-04-10 | Takeda Chemical Industries, Ltd. | Procede pour le criblage preventif / le traitement des maladies d'os ou d'articulations |
JP2006514822A (ja) | 2002-07-02 | 2006-05-18 | ザ ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム | トロンビンペプチド誘導体 |
ATE357928T1 (de) | 2003-12-31 | 2007-04-15 | Orthologic Corp | Pharmazeutische zusammensetzung für thrombinpeptidderivaten |
ES2370040T3 (es) | 2005-10-07 | 2011-12-12 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.R.L. | Vacuna de metaloproteinasa 11 de la matriz. |
CN101965193A (zh) * | 2006-11-15 | 2011-02-02 | 科达治疗公司 | 用于伤口愈合的改进方法和组合物 |
KR101629504B1 (ko) * | 2014-04-14 | 2016-06-10 | 주식회사 엘지생활건강 | 사이토카인 조합을 함유하는 피부 상태 개선용 조성물 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01279840A (ja) * | 1988-04-28 | 1989-11-10 | Wakunaga Pharmaceut Co Ltd | 新規外用組成物 |
GB9405076D0 (en) * | 1994-03-16 | 1994-04-27 | Inst Of Ophtalmology | A medical use of matrix metalloproteinase inhibitors |
-
1999
- 1999-12-29 GB GBGB9930768.8A patent/GB9930768D0/en not_active Ceased
-
2000
- 2000-12-21 CA CA002395487A patent/CA2395487A1/en not_active Abandoned
- 2000-12-21 AU AU18782/01A patent/AU1878201A/en not_active Abandoned
- 2000-12-21 WO PCT/IB2000/001935 patent/WO2001049309A2/en not_active Application Discontinuation
- 2000-12-21 CO CO00097188A patent/CO5271671A1/es not_active Application Discontinuation
- 2000-12-21 EP EP00981550A patent/EP1242120A2/en not_active Withdrawn
- 2000-12-21 JP JP2001549676A patent/JP2003519193A/ja not_active Withdrawn
- 2000-12-22 GT GT200000224A patent/GT200000224A/es unknown
- 2000-12-27 AR ARP000106960A patent/AR027122A1/es not_active Application Discontinuation
- 2000-12-27 PE PE2000001405A patent/PE20011095A1/es not_active Application Discontinuation
- 2000-12-28 UY UY26514A patent/UY26514A1/es not_active Application Discontinuation
- 2000-12-28 EC EC2000003859A patent/ECSP003859A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2395487A1 (en) | 2001-07-12 |
AU1878201A (en) | 2001-07-16 |
GT200000224A (es) | 2002-06-15 |
PE20011095A1 (es) | 2001-10-27 |
ECSP003859A (es) | 2002-09-27 |
EP1242120A2 (en) | 2002-09-25 |
GB9930768D0 (en) | 2000-02-16 |
UY26514A1 (es) | 2001-07-31 |
JP2003519193A (ja) | 2003-06-17 |
WO2001049309A2 (en) | 2001-07-12 |
WO2001049309A3 (en) | 2002-02-28 |
CO5271671A1 (es) | 2003-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0200782A (pt) | Compostos para o tratamento da isquemia | |
CU23423B7 (es) | Oxazolidinonas sustituidas y su uso en el campo de la coagulación sanguínea | |
AR010385A1 (es) | Compuesto derivado de propiofenona, proceso para su preparacion, composicion farmaceutica que lo contiene y uso de dicho compuesto. | |
ES2058892T3 (es) | Uso de omeprazol como agente antimicrobiano. | |
ES2065471T3 (es) | Composiciones acuosas antibacterianas que comprenden un tensoactivo y bacteriofagos. | |
PA8468401A1 (es) | Compuestos para el tratamiento de la isquemia | |
UY26724A1 (es) | Métodos y composiciones para tratar el virus de la hepatitis c | |
PE20010286A1 (es) | Derivados de indoloxoacetil piperazina como agentes antivirales | |
PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
BR0014384A (pt) | Compostos para o tratamento da isquémia | |
ATE218581T1 (de) | Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung | |
AR007582A1 (es) | Composicion para el lavado de la piel, procedimiento para prepararla y el uso de la misma para la fabricacion de medicamentos dado el caso, para eltratamiento cosmetico de la piel. | |
ES2083597T3 (es) | Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado. | |
AR027122A1 (es) | Composicion paa el tratamiento de tejidos danados | |
MD20020075A (en) | Antimicrobial preparation with retarded release of the biologically active component, utilization thereof and process for implant obtaining | |
ES2173923T3 (es) | Procedimiento que permite inactivar un virus en presencia de un polieter y de un agente. | |
ES2174921T3 (es) | Inhibidores de la proteasa del vih. | |
ECSP930933A (es) | Composicion farmaceutica y procedimiento para prepararla | |
AR022250A1 (es) | Envase farmaceutico de uso para el tratamiento y prevencion de infecciones por el virus de la hepatitis b, procedimiento para el tratamiento de pacientes o pacientes susceptibles en padecer infecciones por el virus de la hepatitis b. | |
DE69909747D1 (de) | Pharmazeutische zusammensetzung, enthaltend peg-asparaginase, für die behandlung von hiv infektionen | |
ES2192779T3 (es) | Modificacion cristalina de 1-(2,6-difluorbencil)-1h-1,2,3-triazol-4-carboxamida y su uso como antiepileptico. | |
AU2001238332A1 (en) | Method of sterilizing articles | |
AR037496A1 (es) | Uso novedoso del 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano y sus sales fisiologicamente aceptables | |
AR005730A1 (es) | Forma de fanciclovir, procedimiento para prepararla, composiciones farmaceuticas que la contienen y metodo para el tratamiento o profilaxis deinfecciones virales y el uso de dicha forma -fanciclovir monoidrato. | |
CO5271686A1 (es) | Nuevo uso de (r)-(-)-2-[5-(4-flurofenil)-3-piridilmetil- aminometil]-cromano y de sus sales aceptables para uso fisiologico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |